CNO Financial Group, Inc. — fact timeline

CNO Financial Group, Inc. reported first quarter 2026 results: net income $38 million, or $0.39 per diluted share, EPS $0.39 per diluted share.

“first quarter 2026 financial results: • First quarter performance reflects disciplined execution and the strength of our diversified products and distribution. • Net income was $38 million, or $0.39 per diluted share, and net operating income (1) was $101 million, or $1.05 per diluted share. • Return on equity (ROE) of 9.5%; Operating ROE (5) of 12.2%, excluding”

Jessica A. Turner was appointed as Independent Director at CNO Financial Group, Inc..

“On October 1, 2024, the Board of Directors (the “Board”) of CNO Financial Group, Inc. (the “Company”) appointed Jessica A. Turner to serve as an independent director”

CNO Financial Group, Inc. incurred senior notes of $700.0 million with U.S. Bank Trust Company, National Association at 6.450% maturing June 15, 2034.

“LLC and Barclays Capital Inc., as representatives of the several underwriters listed therein (the “Underwriters”), in connection with the offer and sale by the Company of $700.0 million of 6.450% senior notes due 2034 (the “Notes”). The Company closed its public offering of the Notes on May 13, 2024. The Notes were issued under the Indenture, dated as of June”

CNO Financial Group, Inc. amended Third Supplemental Indenture with U.S. Bank Trust Company, National Association (effective 2024-05-13).

“The Notes were issued under the Indenture, dated as of June 12, 2019 (the “Base Indenture”) as supplemented by the Third Supplemental Indenture, dated as of May 13, 2024 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), each between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”).”

CNO Financial Group, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, RBC Capital Markets, LLC and Barclays Capital Inc. valued at $700.0 million (effective 2024-05-08).

“On May 8, 2024, CNO Financial Group, Inc. (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, RBC Capital Markets, LLC and Barclays Capital Inc., as representatives of the several underwriters listed therein (the “Underwriters”), in connection with the offer and sale by the Company of $700.0 million of 6.450% senior notes due 2034 (the “Notes”).”

CNO Financial Group, Inc. shareholders approved Approve adoption of Amended and Restated Section 382 Shareholder Rights Plan at the 2024-05-09 meeting.

“Proposal 4: The proposal to approve the adoption of the Amended and Restated Section 382 Shareholder Rights Plan was approved.”

CNO Financial Group, Inc. shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2024 at the 2024-05-09 meeting.

“Proposal 3: The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2024 was approved.”

CNO Financial Group, Inc. shareholders approved Advisory vote to approve executive compensation at the 2024-05-09 meeting.

“Proposal 2: The proposal to approve, by non-binding advisory vote, the executive compensation of the Company’s named executive officers disclosed in the Proxy Statement was approved.”

CNO Financial Group, Inc. shareholders approved Election of eight nominees to serve as directors for a one-year term at the 2024-05-09 meeting.

“Proposal 1: The eight nominees to serve as directors of the Company were elected, each for a one-year term expiring at the Company’s 2025 annual meeting of shareholders and until his or her successor is duly elected and qualified.”

CNO Financial Group, Inc. reported the quarter ended March 31, 2024 results: net income net income of $112.3 million, or $1.01 per diluted share, EPS $1.01 per diluted share. Guidance reaffirmed.

“CNO Financial Group, Inc. (NYSE: CNO) today reported net income of $112.3 million, or $1.01 per diluted share, in 1Q24 compared to a net loss of $0.8 million, or $0.01 per diluted share, in 1Q23.”